Plain-English translation of NCT05022862 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two new approaches—video check-ins with a healthcare worker and/or financial incentives—can help people with latent tuberculosis complete their prescribed treatment. Latent tuberculosis is a dormant infection that doesn't make you sick yet, but can become active later if untreated. The study compares these new approaches to standard care to see which works best at helping people stick with their medication over several months.
Many people with latent tuberculosis stop taking their medication before finishing the full course, even though completing treatment is crucial to prevent the infection from becoming active. This trial is testing whether video monitoring and money rewards can motivate people to keep taking their medicine, especially for people facing challenges like poverty, unstable housing, or language barriers.
You likely qualify if…
You likely don't qualify if…
You will take your latent tuberculosis medication as prescribed for either 3 or 4 months, depending on which regimen your doctor chose. Depending on which group you're assigned to, you'll either receive standard care, or use video check-ins where you show a healthcare worker you're taking your medication, or use video check-ins plus earn small financial payments when you successfully submit videos. The study will track whether you complete at least 80% of your prescribed doses using a special pill bottle cap that records when it opens.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States